NASDAQ: TARSTarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?
Insider buying vs selling
Have Tarsus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dianne C. Whitfield | Chief Human Resources Officer | 2024-03-18 | 4,314 | $30.60 | $132.01kSell |
| Bryan Wahl | General Counsel | 2024-03-18 | 4,436 | $30.60 | $135.74kSell |
| Seshadri Neervannan | Chief Operating Officer | 2024-03-18 | 4,879 | $30.60 | $149.30kSell |
| Aziz Mottiwala | Chief Commercial Officer | 2024-03-18 | 4,766 | $30.60 | $145.84kSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2024-03-18 | 10,415 | $30.60 | $318.70kSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2023-12-27 | 8,000 | $20.22 | $161.76kSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2023-12-20 | 30,557 | $20.36 | $622.14kSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2023-12-20 | 9,443 | $19.96 | $188.48kSell |
| Jose M. Trevejo | CHIEF MEDICAL OFFICER | 2023-12-20 | 2,252 | $20.00 | $45.04kSell |
| Andrew D. Goldberg | Director | 2023-12-15 | 1,000 | $18.96 | $18.96kBuy |
TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TARS insiders and whales buy or sell their stock.
TARS Shareholders
What type of owners hold Tarsus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vivo Capital Ix LLC | 16.70% | 5,714,036 | $206.68M | Insider |
| Rtw Investments LP | 9.21% | 3,152,341 | $114.02M | Institution |
| Blackrock Inc | 7.35% | 2,516,139 | $91.01M | Institution |
| Cormorant Asset Management LP | 6.49% | 2,221,422 | $80.35M | Institution |
| Tang Capital Management LLC | 6.44% | 2,204,797 | $79.75M | Institution |
| Rtw Investments LP | 5.88% | 2,013,601 | $72.83M | Insider |
| Horowitz Limited Partnership Viii | 5.81% | 1,987,105 | $71.87M | Insider |
| Morgan Stanley | 5.72% | 1,957,688 | $70.81M | Institution |
| Jason E. Tester | 5.70% | 1,949,331 | $70.51M | Insider |
| Frazier Life Sciences Ix LP | 5.60% | 1,917,157 | $69.34M | Insider |
TARS vs Biotech Stocks
Tarsus Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.